Huamin Wang

Active 1993–2026

355
Papers
41,900
Citations
113
h-index
266
i10-index

Citations

Citations per year for Huamin Wang1994: 2 citations1995: 1 citations1998: 1 citations1999: 3 citations2000: 9 citations2001: 14 citations2002: 13 citations2003: 22 citations2004: 29 citations2005: 36 citations2006: 56 citations2007: 69 citations2008: 102 citations2009: 149 citations2010: 203 citations2011: 217 citations2012: 306 citations2013: 359 citations2014: 400 citations2015: 478 citations2016: 499 citations2017: 599 citations2018: 663 citations2019: 1,636 citations2020: 1,882 citations2021: 1,917 citations2022: 1,439 citations2023: 1,334 citations2024: 1,952 citations2025: 1,160 citations2026: 158 citations1996–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 5,132 citing papers, 27.4% of this breakdownUnited States: 4,643 citing papers, 24.7% of this breakdownUnited Kingdom: 826 citing papers, 4.4% of this breakdownGermany: 824 citing papers, 4.4% of this breakdownItaly: 686 citing papers, 3.7% of this breakdownJapan: 606 citing papers, 3.2% of this breakdownFrance: 534 citing papers, 2.8% of this breakdownCanada: 474 citing papers, 2.5% of this breakdownSouth Korea: 427 citing papers, 2.3% of this breakdownSpain: 340 citing papers, 1.8% of this breakdownAustralia: 330 citing papers, 1.8% of this breakdownIndia: 309 citing papers, 1.6% of this breakdown
0%27.4%Other 19.4%

Fields

  • Medicine36.7%
  • Biochemistry, Genetics and Molecular Biology34%
  • Engineering9.8%
  • Computer Science7.9%
  • Immunology and Microbiology5.1%
  • Chemistry1.9%
  • Other4.6%

Topics

  • Pancreatic and Hepatic Oncology Research6.2%
  • Cancer, Hypoxia, and Metabolism2.7%
  • Cancer Cells and Metastasis2.7%
  • Cancer-related molecular mechanisms research2.3%
  • MicroRNA in disease regulation2.2%
  • Epigenetics and DNA Methylation2.1%
  • Other81.8%

Coauthors

All papers

Open in search
  1. Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer

    Authors: , , , , , , , - Cancer Cell 2021 cited by 553

  2. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 1,273

  3. Interleukin-17–induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2020 cited by 451

  4. Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer

    Authors: , , , , , , , , , , , , - Cancer Cell 2022 cited by 306

  5. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2022 cited by 379

  6. Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer

    Authors: , , , , , , , , - Nature Communications 2017 cited by 635

  7. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer.

    Authors: , , , , , , , , , , , , , , , - Cancer Discovery 2022 cited by 301

  8. Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer

    Authors: , , , , , , , , , , , - Cell 2020 cited by 278

  9. Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation

    Authors: , , , , , , , - Nature Communications 2019 cited by 521

  10. Cell Surface Lactate Receptor GPR81 Is Crucial for Cancer Cell Survival

    Authors: , , , , , , , , , , - Cancer Research 2014 cited by 322

  11. Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2014 cited by 735

  12. Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2020 cited by 208

  13. Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression

    Authors: , , , , , , , , , , , , , - Hepatology 2017 cited by 1,341

  14. Volatile and Nonvolatile Memristive Devices for Neuromorphic Computing

    Authors: , , , , , , , , , , , , , , , , - Advanced Electronic Materials 2022 cited by 237

  15. Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 327

  16. Acute kidney injury in China: a cross-sectional survey

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shaomei Li, Yan Zha, Qiong Luo, Dongcheng Chen, Yulan Shen, Yunhua Liao, Zhengrong Zhang, Xianqiu Wang, Kun Zhang, Luojin Liu, Peiju Mao, Chunxiang Guo, Jiangang Li, Zhenfu Wang, Shoujun Bai, Shuangjie Shi, Yafang Wang, Jinwei Wang, Zhangsuo Liu, Fang Wang, Dandan Huang, Shun Wang, Shuwang Ge, Quanquan Shen, Ping Zhang, Lihua Wu, Miao Pan, Xiting Zou, Ping Zhu, Jintao Zhao, Minjie Zhou, Lin Yang, Lin Yang, W. Hu, Jing Wang, Bing Liu, Tong Zhang, Jianxin Han, Tao Wen, Ming‐Hui Zhao, Haiyan Wang - The Lancet 2015 cited by 473

  17. Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jin Wang, Qizhi Yao, Bing Zhang, Jack A. Roth, Bert W. O’Malley, Matthew J. Ellis, Mothaffar F. Rimawi, Haoqiang Ying, Xi Chen - Science 2023 cited by 110

  18. Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2020 cited by 204

  19. A chebyshev semi-iterative approach for accelerating projective and position-based dynamics

    Authors: - ACM Transactions on Graphics, ACM Trans. Graph. 2015 cited by 153

  20. VR-GS: A Physical Dynamics-Aware Interactive Gaussian Splatting System in Virtual Reality

    Authors: , , , , , , , , , , - Special Interest Group on Computer Graphics and Interactive Techniques Conference Conference Papers, SIGGRAPH (Conference Paper Track) 2024 cited by 117

  21. Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cancer 2022 cited by 87

  22. Second-order Stencil Descent for Interior-point Hyperelasticity

    Authors: , , , , - ACM Transactions on Graphics, ACM Trans. Graph. 2023 cited by 37

  23. Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer

    Authors: , , , , , , , , , , - Gastroenterology 2020 cited by 154

  24. Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - npj Precision Oncology 2024 cited by 82